Eli Lilly and Co’s potential weight-loss drug tirzepatide has shown positive results in a Phase III clinical trial, indicating at the therapy’s potential for patients with obesity and diabetes. Tirzepatide represents a new class of medicines which are currently being investigated for the treatment of obesity. It works by activating the body’s hormone receptors for […]
Menu ≡ ╳ 
